scholarly article | Q13442814 |
P50 | author | Amelie Lupp | Q88477487 |
Markus H Gräler | Q90287179 | ||
P2093 | author name string | Ralf A Claus | |
Ha-Yeun Chung | |||
Jorge Hurtado-Oliveros | |||
C Julius Witt | |||
Jonathan Wickel | |||
P2860 | cites work | Identification of novel functional inhibitors of acid sphingomyelinase | Q21003953 |
Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients | Q24202128 | ||
Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease | Q24337312 | ||
Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis | Q27307089 | ||
A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide | Q28570052 | ||
Amitriptyline Usage Exacerbates the Immune Suppression Following Burn Injury | Q30370188 | ||
Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU | Q30465982 | ||
Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice | Q30881683 | ||
Natural ceramide reverses Fas resistance of acid sphingomyelinase(-/-) hepatocytes. | Q31629166 | ||
Regulation of cytochrome p450 by inflammatory mediators: why and how? | Q31956717 | ||
Cytochrome p450 and chemical toxicology | Q33308211 | ||
Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis | Q33341419 | ||
Adjustment of Dysregulated Ceramide Metabolism in a Murine Model of Sepsis-Induced Cardiac Dysfunction | Q33624807 | ||
Cytochrome P450 and the individuality of species | Q33720420 | ||
Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis | Q34086900 | ||
Cooperation of liver cells in health and disease | Q34103771 | ||
Sphingomyelinases: enzymology and membrane activity | Q34156320 | ||
Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation. | Q34285232 | ||
Hepatic response to sepsis: interaction between coagulation and inflammatory processes. | Q34303810 | ||
Acid sphingomyelinase serum activity predicts mortality in intensive care unit patients after systemic inflammation: a prospective cohort study | Q34482934 | ||
Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. | Q35038284 | ||
Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis | Q35607603 | ||
Anti-inflammatory properties of desipramine and fluoxetine | Q35807992 | ||
Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism | Q35824374 | ||
Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model | Q36605868 | ||
Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate | Q37515719 | ||
The role of hepatic cytochrome P-450 in sepsis | Q37633942 | ||
Pharmacokinetics and pharmacodynamics in critically ill patients | Q37758059 | ||
The liver in sepsis: patterns of response and injury. | Q38085448 | ||
Approaches for dosage individualisation in critically ill patients. | Q38125209 | ||
Liver - guardian, modifier and target of sepsis | Q39031051 | ||
Comprehensive comparison of three different animal models for systemic inflammation | Q40081335 | ||
Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone | Q40400123 | ||
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations | Q40491993 | ||
Acid sphingomyelinase promotes endothelial stress response in systemic inflammation and sepsis | Q40637739 | ||
ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis | Q41921041 | ||
Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver | Q41993606 | ||
A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. | Q42604349 | ||
Age-related changes in hepatic expression and activity of cytochrome P450 in male rats. | Q43174287 | ||
Sterol affinity for bilayer membranes is affected by their ceramide content and the ceramide chain length | Q43203609 | ||
PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. | Q44712899 | ||
Cytochrome P-450 activity is differentially altered in severely injured patients | Q45309305 | ||
A simple and sensitive assay of 7-ethoxycoumarin deethylation | Q46527161 | ||
Developmental pharmacology and toxicology: biotransformation of drugs and other xenobiotics during postnatal development | Q46595798 | ||
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety | Q46902575 | ||
Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas | Q47108225 | ||
Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. | Q52266254 | ||
Sepsis and septic shock: Pathogenesis and treatment perspectives. | Q53742291 | ||
Hepatic Fibrosis in a Long-term Murine Model of Sepsis. | Q54327914 | ||
Substantial performance discrepancies among commercially available kits for reverse transcription quantitative polymerase chain reaction: a systematic comparative investigator-driven approach. | Q54437313 | ||
Raft Domain Reorganization Driven by Short- and Long-Chain Ceramide: A Combined AFM and FCS Study | Q57366647 | ||
CD95 Signaling via Ceramide-rich Membrane Rafts | Q57371964 | ||
Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat | Q70082884 | ||
Sensitive formaldehyde determination with Nash's reagent and a 'tryptophan reaction' | Q70458450 | ||
Postnatal development and sublobular distribution of cytochrome P-450 in rat liver: a microphotometric study | Q70551141 | ||
A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions | Q71522867 | ||
Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture | Q71739388 | ||
Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes | Q71743477 | ||
Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture | Q72584826 | ||
The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity | Q77910282 | ||
Quantification of sphingosine-1-phosphate and related sphingolipids by liquid chromatography coupled to tandem mass spectrometry | Q83974262 | ||
Characteristics of clinical sepsis reflected in a reliable and reproducible rodent sepsis model | Q84518230 | ||
Effects of age increase on hepatic expression and activity of cytochrome P450 in male C57BL/6 mice | Q87442049 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sepsis | Q183134 |
ceramides | Q424213 | ||
murine model | Q122890741 | ||
P577 | publication date | 2018-10-15 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | Acid Sphingomyelinase Inhibition Stabilizes Hepatic Ceramide Content and Improves Hepatic Biotransformation Capacity in a Murine Model of Polymicrobial Sepsis | |
P478 | volume | 19 |
Search more.